Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Konstantine T Kalogeras
Evaluation of the Prognostic Role of Centromere 17 Gain and HER2/topoisomerase II Alpha Gene Status and Protein Expression in Patients With Breast Cancer Treated With Anthracycline-Containing Adjuvant Chemotherapy: Pooled Analysis of Two Hellenic Cooperative Oncology Group (HeCOG) Phase III Trials
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer
Turk Patoloji Dergisi
Forensic Medicine
Pathology
Pathogenic Mutations and Overall Survival in 3,084 Patients With Cancer: The Hellenic Cooperative Oncology Group Precision Medicine Initiative
Oncotarget
Oncology
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
PLoS ONE
Multidisciplinary
Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group
British Journal of Cancer
Cancer Research
Oncology
